GC Aesthetics®, Inc. (GCA), a privately-held medical tech firm providing Women Healthcare Aesthetic and Reconstructive Solutions, has announced its growth and expansion plans for the Brazilian market, the second largest Breast Augmentation market in the world.
What is the market offering of GC Aesthetics®?
GC Aesthetics® has been executing an ambitious journey repositioning the brand and portfolio to offer a smart, unique, and clinically proven safe range of products to meet the needs of Brazilian women and surgeons. The Brazilian growth strategy includes 2 main pillars.
First, the commercialization of all GC Aesthetics® solutions designed to support the best outcome for women’s breast enhancement journey, before, during and after surgery. This unique portfolio not only stands out in the industry but is aligned with the firm’s leadership and growing plans evolving from Breast Implant Manufacturers to Solution Providers.
The Brazilian revenue growth of GC Aesthetics® is also linked to the ANVISA certificate (Brazilian Health Regulatory Agency) just obtained for the re-introduction of The Round Collection™ Breast Implants. This unique microtextured surface breast implant has been the preferred option by surgeons in Brazil: 99% of all the surveyed Plastic Surgeons consider The Round Collection™ as the trustable product in terms of safety and performance.
What were the executives’ thoughts on the expansion?
“According to our most recent survey, long-term proven safety & the unique type of micro texture are the 2 top reasons Brazilian Plastic Surgeons prefer The Round Collection Implants against competitors,” commented Carlos Reis Pinto, CEO of GC Aesthetics®.
“We are excited to be back in Brazil and offer Surgeons and Patients, a proven long-term, safe and reliable medical device. Pre-orders of this product have exceeded what we had planned, and we are looking forward to a very bright, leading future in Brazil and in the world”
“At GCA®, we are dedicated to advancing the science of medical aesthetics and delivering exceptional clinical, operational and commercial performance to be the preferred partner of surgeons and physicians worldwide, we are excited for The Round Collection™ re-entry in Brazil and are excited of presenting our brand as ONE GCA,” said Ron Cosmas, CCO, GCA®.
GC Aesthetics® will be presenting the re-introduction of this product at the Jornada Paulista de Cirurgia Plástica, held from June 15th to the 18th at the WTC São Paulo, Brazil.
Engineered for performance The Round Collection™ breast implants have a long-term safety profile. The Round Collection™ by GC Aesthetics® is part of the largest European long-term clinical study for breast implants with exceptional results at 10 years and recently had data published in a one-of-a-kind 17 year patient follow-up with remarkable patient satisfaction.
